Publix and Fresh Express Spinach Recall Issued Due To Health Risk from Listeria Monocytogenes

Testing has revealed that bagged spinach products sold in seven states may expose consumers to a risk of listeria food poisoning infections

Federal health officials have announced a bagged spinach recall, warning that certain Publix and Fresh Express brand spinach products may pose a risk of listeria food poisoning, potentially causing serious and potentially life-threatening infections.

The U.S. Food and Drug Administration (FDA) announced the spinach recall on December 15, warning consumers to stop eating bagged spinach products branded under the Fresh Express and Publix product names that were sold in multiple states throughout the U.S.

The recalled spinach may be contaminated with listeria monocytogenes, which poses a particularly serious risk for vulnerable individuals, including children, senior adults, and those with weakened immune systems. Healthy individuals may experience short-term symptoms, including fever, headaches, stiffness, abdominal pain, nausea, and diarrhea from listeria monocytogenes infections, while pregnant women may suffer more severe consequences, including miscarriages and stillbirths.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

Fresh Express & Publix Spinach Recall

The spinach recall was issued after routine testing by the Florida Department of Agriculture identified the presence of listeria in a randomly selected package of Fresh Express spinach. After being notified of the positive sample, Fresh Express immediately began instructing distributors and retailers to remove potentially impacted bagged spinach products from store shelves.

The recall impacts Fresh Express Spinach sold in 8 ounce bags, and Publix Spinach sold in 9 ounce bags, that were distributed throughout Alabama, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Virginia, including packaged spinach kits with product code G332 and use-by dates of December 14, 2023 or December 15, 2023.

Consumers may contact the Fresh Express consumer response center at (800) 242-5472 from 8 A.M. to 7 P.M. EST for a refund or for more information on the recall.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Lawsuit Alleges Suboxone Caused Dental Damage, Erosion and Tooth Decay
Lawsuit Alleges Suboxone Caused Dental Damage, Erosion and Tooth Decay (Posted today)

Kentucky man has filed a lawsuit against Suboxone manufacturers, indicating the opioid treatment film strips were known for years to cause the kind of permanent tooth damage he suffered, long before warning labels were added by the drug manufacturer.

Master Complaint Outlines Allegations in Ozempic, Wegovy, Mounjaro Lawsuits in MDL
Master Complaint Outlines Allegations in Ozempic, Wegovy, Mounjaro Lawsuits in MDL (Posted 3 days ago)

Plaintiffs pursuing GLP-1 injury lawsuits have filed a Master Complaint outlining common allegations being pursued against Novo Nordisk and Eli Lilly over their diabetes and weight loss drugs, including Ozempic, Wegovy, Mounjaro and others.

Six Years of Depo-Provera Injections Caused Woman To Develop Intracranial Meningioma: Lawsuit
Six Years of Depo-Provera Injections Caused Woman To Develop Intracranial Meningioma: Lawsuit (Posted 4 days ago)

California woman indicates she was unaware there was a link between her meningioma and Depo-Provera injections until a study was published in March 2024, resulting in widespread publicity about the brain tumor risks.